Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2026-01-21 @ 6:26 AM
Study NCT ID:
NCT00193466
Status:
COMPLETED
Last Update Posted:
2010-12-30
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
SCRI Development Innovations, LLC
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SCRI LYM 21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
John D. Hainsworth, M.D.
Old Organization:
Sarah Cannon Research Institute
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |